Literature DB >> 513713

Characterization and comparison of the estrogen and androgen receptors from the R-3327 rat prostatic adenocarcinoma.

F S Markland, L Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 513713     DOI： 10.1016/0022-4731(79)90135-3

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN： 0022-4731            Impact factor:   4.292


× No keyword cloud information.
  5 in total

1.  Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

Authors:  T W Redding; A V Schally; T R Tice; W E Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

2.  Analysis of changes in rat prostate carcinoma following hormone deprivation.

Authors:  W C Beckman; A L Jacokes; J L Camps; R L Cook; G P Siegal
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

3.  Prostate carcinoma tumor size in rats decreases after administration of antagonists of luteinizing hormone-releasing hormone.

Authors:  T W Redding; D H Coy; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

4.  Gestagens in the management of prostatic carcinoma.

Authors:  Z Szendröi
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

5.  Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

Authors:  T W Redding; A V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.